Breakthrough Therapies in Guillain-Barré Syndrome Market: What to Expect
Guillain-Barré Syndrome (GBS) is a rare and serious autoimmune disorder in which the body’s immune system attacks its own peripheral nerves, often resulting in rapid-onset muscle weakness and, in severe cases, paralysis. As the healthcare industry puts a stronger focus on rare diseases, the Guillain-Barré Syndrome Market is gaining traction with new research initiatives and...
0 Comments 0 Shares 54 Views 0 Reviews